Cannabis Control Commission Public Meeting
In accordance with Sections 18-25 of Chapter 30A of the Massachusetts General Laws, notice is hereby given of a meeting of the Cannabis Control Commission:
November 1, 2018
1:00 PM
Location:
Health Policy Commission
50 Milk Street, 8th Floor
Boston, MA 02109
In-Person with Remote Access via Microsoft Teams Live*
Public Meeting Agenda
1) Call to Order
2) Chairman’s Comments & Updates
3) Executive Director’s Report
a. Staffing Update
b. License Applications
4) Staff Recommendations on Final Licenses
a. New England Treatment Access, LLC (# MC281267), Cultivation, Tier 6—Indoor
b. New England Treatment Access, LLC (# MP281306), Product Manufacturer
c. Pharmacannis Massachusetts, Inc. (# MR281252), Retail
d. SIRA Naturals, Inc. (# MC281252), Cultivation, Tier 3—Indoor
e. SIRA Naturals, Inc. (# MP281303), Product Manufacturer
f. SIRA Naturals, Inc. (# MX281310), Transporter with Other Existing ME License
5) Staff Recommendations on Provisional License Applications
a. Ashli’s Extract, Inc. (# MPN281374), Product Manufacturer
b. Ashli’s Farm, Inc. (# MCN281451), Cultivation, Tier 4—Indoor
c. Ashli’s, Inc. (# MRN281332), Retail
d. Gibby’s Garden, LLC (# MBN281347), Microbusiness—Tier 1/Indoor Cultivation and Product Manufacturing
e. Green Biz, LLC (# MRN281490), Retail
f. Sanctuary Medicinals, Inc. (# MCN281308), Cultivation, Tier 5—Indoor
g. Sanctuary Medicinals, Inc. (# MPN281405), Product Manufacturer
h. Temescal Wellness of Massachusetts, Inc. (# MCN281550), Cultivation, Tier 2—Indoor
i. Temescal Wellness of Massachusetts, Inc. (# MPN281402), Product Manufacturer
j. Theory Wellness, Inc. (# MCN281524), Cultivation, Tier 1—Indoor
k. Theory Wellness, Inc. (# MPN281424), Product Manufacturer
6) Commission Discussion and Votes
a. Enhanced Code of Ethics
b. Summary Discussion of Comments Received for Draft Regulations on Medical Use of Marijuana
7) New Business that the Chairman did not anticipate at time of posting
8) Next Meeting Date
Notice of Executive Session
Under the Open Meeting Law, G.L. c. 30A, § 21(a)(4) and (7) and the Public Records Law, G.L. c. 66, and the exemptions set forth in G.L. c. 4, § 7(26)(a), (f) and (n), the Commission may enter into executive session on the following agenda items:
1) to discuss provisional licensees’ qualifications for final licensure, including, but not limited to, the Commission staff’s strategies for reviewing, inspecting, and monitoring the proposed security plans of the Marijuana Establishment and for the marijuana and marijuana products
